AZRX

Is AzurRx (AZRX) About to Transform the Gastrointestinal Treatment Industry?
  • Is AzurRx (AZRX) About to Transform the Gastrointestinal Treatment Industry?

Is AzurRx (AZRX) About to Transform the Gastrointestinal Treatment Industry?

By |January 5th, 2017|

AzurRX BioPharma Inc (NASDAQ: AZRX)

As a goal, I strive to find emerging companies that are hidden gems in an industry: ones that are in a position to cause a paradigm shift in technology, benefiting not only investors, but also rewards recipients of that technology with a better method of treatment or service.

For AzurRx, the […]

AzurRx BioPharma (AZRX) Stock: An Emerging Leader to Treat Gastrointestinal Disease
  • AzurRx BioPharma (AZRX) Stock: An Emerging Leader to Treat Gastrointestinal Disease

AzurRx BioPharma (AZRX) Stock: An Emerging Leader to Treat Gastrointestinal Disease

By |December 27th, 2016|

AzurRX BioPharma, Inc (NASDAQ: AZRX)

AzurRx has been generating a lot of attention lately. And, while many emerging companies tend to get some early nods from investors and analysts, the focus on AZRX has strong fundamental underpinnings.

AzurRx is developing a broad pipeline of non-systemic biologics to treat gastrointestinal (GI) and infectious diseases. Importantly, for AzurRx […]